Results 251 to 260 of about 2,181,002 (405)

Trainee finances [PDF]

British Dental Journal, 2008
openaire   +2 more sources

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Curative care expenditure across different comorbidity states of chronic hepatitis B: a prevalence study in Sichuan Province, China. [PDF]

BMJ Open
Qiaoying W, Lanming F, Yang L, Jia L, Qun S, Yuelin Z.   +5 more
europepmc   +1 more source

Informal Finance and Financial Market Integration in El Salvador

, 2015
Carlos E. Cuevas, Graham, Douglas H.
openalex   +1 more source

Optimal Feature Selection for Market Risk Assessment: A Dimensional Reduction Approach in Quantitative Finance

Zhijie Wu
openalex   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Dental Care and Oral Health Within the Framework of Bulgarian Public Health Financing. [PDF]

Healthcare (Basel)
Raycheva R, Popova-Sotirova I, Musurlieva N.   +2 more
europepmc   +1 more source

Segmented Capital Markets and the Cost of External Finance

, 2000
Matthew T. Billett, Jon A. Garfinkel
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

What affects the performance of hospital financing interventions in low and lower-middle income countries from the program design and implementation perspective? A scoping review. [PDF]

Health Policy Plan
Zeng W, Boiangiu M, Trachsel N, Jarawan E, Turbat V, Meessen B.   +5 more
europepmc   +1 more source